JUN 13, 2019 9:57 PM PDT

Formation of Habitual Cannabis Use Drives Addiction

WRITTEN BY: C Reardon

According to a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published by Elsevier, shifting from brain systems controlling reward-driven use to habit-driven use is what differentiates between addicted heavy cannabis users and those who are not addicted, even if they are long-time users.

Through the use of brain imaging, this study monitored neural activity as cannabis users were shown images associated with their cannabis use. Researchers refer to this as drug cues. Based on their findings, it appears that although all users reported being heavy, long-term users, only some were truly dependent on the drug. 

It turned out that all users in the study had exaggerated responses in their ventral striatum, the region of the brain that recognizes and processes reward. With a strong connection to other emotion generators in the brain, this region is most active during the expectancy, and receipt of, monetary, social, and emotional rewards. 

However, those users that proved to be dependent on the drug had a noticeably larger response in the dorsal striatum as well. The dorsal striatum is the region of the brain where habits are formed. The dorsal striatum is heavily involved in the planning, execution, and automatization of our motor behavior.  

What this means is that heavy cannabis use is a result of changes in your brain's reward system, but this may not be an indicator of an addictive relationship with the drug. Addictive qualities are likely controlled by the brain system that promotes habit and habitual use. Those who were dependent on the drug saw changes in other regions of the brain as well.

With an increasing cannabis landscape, it is crucial to begin to understand what causes cannabis users to develop addictive qualities when it comes to this drug. In terms of treatment, these findings could be beneficial in assisting the many long-term, heavy users that are now addicted to this drug. 


 

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
JUL 12, 2020
Cell & Molecular Biology
Lung Cancer is Different in Non-Smokers
JUL 12, 2020
Lung Cancer is Different in Non-Smokers
Not everyone that gets lung cancer is a current or former smoker, and researchers have now found that lung cancer is dif ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
JUL 17, 2020
Cannabis Sciences
Does Cannabis Really Make Sex Better?
JUL 17, 2020
Does Cannabis Really Make Sex Better?
Cannabis is legal in 39 states. While it is entirely legal in 11 states and the District of Columbia, in another 28, it ...
JUL 20, 2020
Cancer
Fighting Cancer with Black Pepper
JUL 20, 2020
Fighting Cancer with Black Pepper
In the never-ending search for the next treatment or cure, many researchers turn towards nature. The study of black pepp ...
JUL 30, 2020
Immunology
Gene Silencing Therapy Stops the Itch of Psoriasis
JUL 30, 2020
Gene Silencing Therapy Stops the Itch of Psoriasis
A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion co ...
AUG 01, 2020
Cardiology
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
AUG 01, 2020
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
Type 2 diabetes affects millions around the world.  By itself, it prevents your body from properly using sugars fro ...
Loading Comments...